Monroe Ewabo *Optimal Selection™ Tested

DNA Health Testing

DNA & Optimal Selection™ Panel - CLEAR of:

*HIGHLIGHTS*

Blood Disorders

• Canine Scott Syndrome (CSS)
• Hemophilia A (Factor VIII Deficiency)
• Hemophilia B (Factor IX Deficiency)
• Phosphofructokinase Deficiency (PFK)
• Prekallikrein Deficiency
• Pyruvate kinase deficiency (PKD)
• Von Willebrand's Disease (vWD), type 1, type 2, type 3

Ocular Disorders

• Juvenile Hereditary Cataracts (JHC - HSF4)
• Canine Multifocal Retinopathy 1 (CMR1), Canine Multifocal Retinopathy 2 (CMR2), Canine Multifocal Retinopathy 3 (CMR3)
• Cone Degeneration, (CD)
• Cone-Rod Dystrophy (CRD), Cone-Rod Dystrophy 1 (CRD1), Cone-Rod Dystrophy 2 (CRD2)
• Dominant Progressive Retinal Atrophy (DPRA)
• Early retinal degeneration (ERD)
• Generalized progressive retinal atrophy (GPRA)
• Goniodysgenesis and Glaucoma
• Primary Lens Luxation (PLL)
• Primary Open Angle Glaucoma (POAG)
• Progressive Retinal Atrophy, (PRA), Progressive Retinal Atrophy 1, Progressive Retinal Atrophy III
• Progressive Rod Cone Degeneration (prcd-PRA)
• X-Linked Progressive Retinal Atrophy 1 (XLPRA1), X-Linked Progressive Retinal Atrophy 2 (XLPRA2)
• Rod-Cone Dysplasia 1, Rod-Cone Dysplasia (rcd1a), Rod-Cone Dysplasia 3 (rcd3)

Cardiac Disorders

• Dilated cardiomyopathy (DCM)
• Long QT Syndrome (LQTS)

Endocrine Disorders

• Congenital Dyshormonogenic Hypothyroidism (CDH)
• Congenital Hypothyroidism

Immunological Disorders

• Severe Combined Immunodeficiency (ARSCID), Severe Combined Immunodeficiency (SCID)
• X-linked Severe Combined Immunodeficiency (XSCID)

Renal Disorders

• 2,8-dihydroxyadenine (DHA) Urolithiasis
• Renal Cystadenocarcinoma and Nodular Dermatofibrosis (RCND)
• Protein Losing Nephropathy (PLN)
• Polycystic Kidney Disease (PKD)
• Cystinuria Type I-A, Cystinuria Type II-A
• Cystic Renal Dysplasia and Hepatic Fibrosis
• Hyperuricosuria, (HUU)

Metabolic Disorders

• Glycogen Storage Disease Type IIIa, (GSD IIIa), Glycogen Storage Disease Type Ia
• Intestinal Cobalamin Malabsorption (ICM) or Imerslund-Gräsbeck Syndrome
• Pyruvate Dehydrogenase Phosphatase 1 (PDP1) Deficiency

Muscular Disorders

• Muscular Dystrophy
• Centronuclear Myopathy (CNM)

Neurological Disorders

• Benign Familial Juvenile Epilepsy (BFJE)
• Juvenile Myoclonic Epilepsy
• Juvenile Encephalopathy
• Neonatal Encephalopathy with Seizures (NEWS)
• Spongiform LeucoEncephaloMyelopathy (SLEM) (Shaking Puppy Syndrome)
• Spinocerebellar Ataxia with Myokymia and/or Seizures (SAMS)
• Deafness and Vestibular Dysfunction

Neuromuscular Disorders

• Congenital Myasthenic Syndrome (CMS)
• Exercise-Induced Collapse (EIC)
• GM1 Gangliosidosis, GM2 Gangliosidosis

Skeletal Disorders

• Chondrodysplasia
• Cleft Lip & Palate with Syndactyly (CLPS)
• Cleft Palate (CP)
• Craniomandibular Osteopathy (CMO)
• Osteochondrodysplasia
• Osteogenesis Imperfecta (OI)
• Hypophosphatasia
• Skeletal Dysplasia 2 (SD2)
• Spondylocostal Dysostosis

Dermal Disorders

• Dystrophic Epidermolysis Bullosa
• Epidermolytic Hyperkeratosis
• Ichthyosis
• Lamellar Ichthyosis, (LI)
• Lethal Acrodermatitis, (LAD)

Other Disorders

• Acute respiratory distress syndrome (ARDS)
• Amelogenesis Imperfecta (AI)
• Lung Developmental Disease
• Primary Ciliary Dyskinesia (PCD)
• MDR1 Medication Sensitivity

Traits

• Piebald Gene

Optimal Selection™ Panel - CARRIER of:

• Degenerative Myelopathy (DM)

Non-DNA Testing/Polygenetic Disease/OFA Certifications

• Patellas - 0/0 -
• Cardiac Normal -